Company profile
NanoZymeX
We Develop Next Generation Enzyme Replacement Therapy for Lysosomal Storage Diseases
- Industry
- Pharmaceutical Manufacturing
- Employees
- 4
NanoZymeX company summary
NanoZymeX is a company in the Pharmaceutical Manufacturing industry. On LinkedIn the company has around 4 employees.
What technology does NanoZymeX use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About NanoZymeX
NanoZymeX is developing a next-generation enzyme replacement therapy that significantly improves treatment efficacy while reducing immune-related side effects. Our approach addresses key limitations of current therapies, offering a more durable and better-tolerated solution for patients with lysosomal storage diseases and other enzyme deficiency disorders.
Compare companies similar to NanoZymeX
More companies in Pharmaceutical Manufacturing.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
NanoZymeX nanozymex.com | Pharmaceutical Manufacturing | 4 | - | - |
 Anacor Pharmaceuticals pfizer.com | Pharmaceutical Manufacturing | 108,102 | - | New York, New York |
 Sanofi sanofi.com | Pharmaceutical Manufacturing | 93,352 | - | Paris, France, FR |
 GSK gsk.com | Pharmaceutical Manufacturing | 92,179 | - | London, England |
 Novartis España novartis.com | Pharmaceutical Manufacturing | 85,373 | - | Basel, Baselstadt |
 AstraZeneca astrazeneca.com | Pharmaceutical Manufacturing | 80,667 | - | Cambridge, Cambridgeshire, GB |
 Eli Lilly and Company lilly.com | Pharmaceutical Manufacturing | 57,202 | - | Indianapolis, Indiana |
 Merck merck.us | Pharmaceutical Manufacturing | 44,794 | - | Rahway, New Jersey |
 SUN PHARMA sunpharma.com | Pharmaceutical Manufacturing | 47,764 | 1983 | Mumbai, Maharastra |
 Boehringer Ingelheim boehringer-ingelheim.com | Pharmaceutical Manufacturing | 47,150 | - | Ingelheim am Rhein, Rhineland-Palatinate |
 Cipla cipla.com | Pharmaceutical Manufacturing | 51,911 | - | Mumbai, Maharashtra |
Frequently asked questions about NanoZymeX
What does NanoZymeX do?
NanoZymeX is developing a next-generation enzyme replacement therapy that significantly improves treatment efficacy while reducing immune-related side effects. Our approach addresses key limitations of current therapies, offering a more durable and better-tolerated solution for patients with lysosomal storage diseases and other enzyme deficiency disorders.
How many employees does NanoZymeX have?
NanoZymeX has around 4 employees on LinkedIn.
Build a lead list from companies like NanoZymeX
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.